Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Debt (2020 - 2023)

Historic Total Debt for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $20.4 million.

  • Candel Therapeutics' Total Debt rose 157.54% to $20.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.4 million, marking a year-over-year increase of 157.54%. This contributed to the annual value of $20.2 million for FY2022, which is 350750.0% up from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Total Debt is $20.4 million, which was up 157.54% from $20.4 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Total Debt registered a high of $20.4 million during Q3 2023, and its lowest value of $463000.0 during Q4 2020.
  • Its 4-year average for Total Debt is $15.8 million, with a median of $20.1 million in 2022.
  • As far as peak fluctuations go, Candel Therapeutics' Total Debt surged by 350750.0% in 2022, and later soared by 157.54% in 2023.
  • Candel Therapeutics' Total Debt (Quarter) stood at $463000.0 in 2020, then increased by 20.95% to $560000.0 in 2021, then soared by 3507.5% to $20.2 million in 2022, then increased by 1.17% to $20.4 million in 2023.
  • Its Total Debt stands at $20.4 million for Q3 2023, versus $20.4 million for Q2 2023 and $20.3 million for Q1 2023.